US Patent Issued to AiVita Biomedical on April 8 for "Use of cell membrane-bound signaling factors" (California Inventor)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,770, issued on April 8, was assigned to AiVita Biomedical Inc. (Irvine, Calif.).

"Use of cell membrane-bound signaling factors" was invented by Gabriel Nistor (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising complexes of cyclodextrins and lipid-modified stem cell proteins. Also disclosed are topical compositions the complexes. Methods of using the compositions for the therapeutic purposes are also disclosed as well as methods of producing the compositions."

The patent was filed on April 26, 2023, under Application No. 18/139,825.

*For further information, including images, charts and table...